THE COST-EFFECTIVENESS OF CANAGLIFLOZIN COMPARED WITH LIRAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH METFORMIN AND SULFONYLUREA IN FRANCE

被引：1

作者：

Troelsgaard, A. ^{[1
]}

Pitcher, A. ^{[2
]}

Granados, D. ^{[3
]}

Hemels, M. ^{[1
]}

Lloyd, A. ^{[2
]}

机构：

[1] Janssen AS, Birkerod, Denmark

[2] IMS Hlth, London, England

[3] Janssen, Paris, France

来源：

VALUE IN HEALTH | 2014年 / 17卷 / 07期

关键词：

D O I：

10.1016/j.jval.2014.08.707

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PDB85

引用

页码：A346 / A347

页数：2

共 50 条

[31] Canagliflozin versus glimepiride treatment in patients with Type 2 diabetes inadequately controlled with metformin (CANTATA-SU trial)
Davis, Stephen N.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (01) : 21 - 23
[32] Effect of Dapagliflozin in Patients with inadequately controlled Type 2 Diabetes with Metformin
Pavlicek, V.
DIABETOLOGE, 2011, 7 (01): : 37 - 38
[33] THE COST-EFFECTIVENESS OF DULAGLUTIDE VERSUS LIRAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN TAIWAN
Lin, H.
Babineaux, S.
Lew, T.
Lowin, J.
Lovato, E.
Strizek, A. A.
Rajan, N.
VALUE IN HEALTH, 2016, 19 (07) : A898 - A898
[34] Cost-effectiveness of Empagliflozin, in Addition to Metformin, in Patients with Type 2 Diabetes in Italy
Mannucci, Edoardo
Ghetti, Gianni
FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2022, 23 (01) : 85 - 95
[35] EVALUATING THE SHORT-TERM COST-EFFECTIVENESS OF LIRAGLUTIDE VERSUS SITAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES FAILING METFORMIN MONOTHERAPY
Langer, J.
Hunt, B.
Valentine, W. J.
VALUE IN HEALTH, 2012, 15 (04) : A180 - A181
[36] Long-term cost-effectiveness analysis of patients with type 2 diabetes mellitus inadequately controlled on thiazolidinedione therapy and either biphasic insulin aspart 30 or sulfonylurea
Nicklasson, L
Palmer, A
Cobden, D
Valentine, W
Roze, S
DIABETOLOGIA, 2005, 48 : A334 - A334
[37] COST-EFFECTIVENESS OF LIRAGLUTIDE IN PEOPLE WITH TYPE 2 DIABETES IN THE SLOVAK REPUBLIC
Ilavska, A.
Uliciansky, V
Wrona, W.
Lacka, J.
Czech, M.
VALUE IN HEALTH, 2010, 13 (07) : A291 - A291
[38] Effectiveness and cost-effectiveness of six GLP-1RAs for treatment of Chinese type 2 diabetes mellitus patients that inadequately controlled on metformin: a micro-simulation model
Yuan, Shuai
Wu, Yingyu
FRONTIERS IN PUBLIC HEALTH, 2023, 11
[39] Treatment failure with sitagliptin compared to sulphonylureas for type 2 diabetes inadequately controlled on metformin
Sharma, M.
Nazareth, I.
Petersen, I.
DIABETOLOGIA, 2017, 60 : S359 - S359
[40] Cost-effectiveness of canagliflozin and dapagliflozin for treatment of patients with chronic kidney disease and type 2 diabetes
Nguyen, Bao-Ngoc
Mital, Shweta
Bugden, Shawn
Nguyen, Hai V.
DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 3030 - 3039

← 1 2 3 4 5 →